Reliability and validity of the Indonesian version of the aging males’ symptoms
DOI:
https://doi.org/10.13181/mji.oa.215314Keywords:
aging males’ symptoms scale, Indonesian, reliability and validityAbstract
BACKGROUND Aging males’ symptoms (AMS) scale was developed to study the problems of aging males, especially related to the quality of life. Currently, there is no valid and reliable Indonesian version of the AMS scale. This study was aimed to translate and evaluate the validity and reliability of the Indonesian version of the AMS scale.
METHODS This cross-sectional study translated the existing AMS scale into Indonesian, which was tested in 40 years old males from May to August 2020. Cross-cultural validation of the AMS scale was conducted by translating the questionnaire from English to Indonesian by two independent-certified translators. The validity of the Indonesian version of the AMS scale was measured by conducting a Pearson correlation (r) analysis. The reliability of this questionnaire was tested and retested in 118 participants with a 2-week interval. In addition, Cronbach’s alpha value was measured and used as a reference. The first test was conducted in a corporate blood donor event in Matraman, East Jakarta, and the retest was conducted in Cipto Mangunkusumo Hospital.
RESULTS The Indonesian version of the AMS scale was valid and had a good internal consistency with a Cronbach’s alpha value of 0.74. The test-retest reliability showed good reliability with an r-value of 0.981. Pearson correlation test showed that all questions in the questionnaire were valid (p<0.05) and correlated positively.
CONCLUSIONS The Indonesian version of the AMS scale derived from this study is valid and has good reliability.
Downloads
References
Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, et al. The aging males' symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes. 2003;1:77. https://doi.org/10.1186/1477-7525-1-77
Heinemann LA, Zimmermann T, Vermeulan A, Thiel C, Hummel W. A new 'aging male's symptoms' rating scale. Aging Male. 1999;2(2):105-14. https://doi.org/10.3109/13685539909003173
Tan HM, Low WY, Tong SF, Haniff J, Appannah G, Lee VK, et al. Aging male symptoms (AMS) for health-related quality of life in aging men: translation and adaptation in Malay. Malaysian J Public Health Med. 2015;15(2):17-23.
Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X, et al. The aging males' symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15. https://doi.org/10.1186/1477-7525-1-15
Stanley RM, Ridley K, Olds TS, Dollman J. Development and psychometric properties of the Y-PASS questionnaire to assess correlates of lunchtime and after-school physical activity in children. BMC Public Health. 2014;14:412. https://doi.org/10.1186/1471-2458-14-412
Rabah DN, Altaweel W, Arafa MA. Clinical assessment and validation of an Arabic aging male symptoms questionnaire in patients with androgen deficiency. Aging Male. 2011;14(1):33-6. https://doi.org/10.3109/13685538.2010.512373
Kong XB, Guan HT, Li HG, Xiong CI. The ageing males' symptoms scale for Chinese men: reliability, validation and applicability of the Chinese version. Andrology. 2014;2(6):856-61. https://doi.org/10.1111/j.2047-2927.2013.00145.x
Park DS, Kim TB, Ku JH, Kim SW, Paick JS. Correlation between androgen deficiency on the aging males questionnaire and the aging males' symptoms scale and their relationship with serum testosterone. Korean J Urol. 2008;49(11):1035-40. https://doi.org/10.4111/kju.2008.49.11.1035
Moore C, Huebler D, Zimmermman T, Heinemman LA, Saad F, Thai DM. The aging males' symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol. 2004;46(1):80-7. https://doi.org/10.1016/j.eururo.2004.01.009
Published
How to Cite
Issue
Section
License
Authors who publish with Medical Journal of Indonesia agree to the following terms:
- Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.
